Lambert Peter A
Pharmaceutical and Biological Sciences, Aston University, Birmingham B4 7ET, United Kingdom.
Adv Drug Deliv Rev. 2005 Jul 29;57(10):1471-85. doi: 10.1016/j.addr.2005.04.003.
Alteration in the target sites of antibiotics is a common mechanism of resistance. Examples of clinical strains showing resistance can be found for every class of antibiotic, regardless of the mechanism of action. Target site changes often result from spontaneous mutation of a bacterial gene on the chromosome and selection in the presence of the antibiotic. Examples include mutations in RNA polymerase and DNA gyrase, resulting in resistance to the rifamycins and quinolones, respectively. In other cases, acquisition of resistance may involve transfer of resistance genes from other organisms by some form of genetic exchange (conjugation, transduction, or transformation). Examples of these mechanisms include acquisition of the mecA genes encoding methicillin resistance in Staphylococcus aureus and the various van genes in enterococci encoding resistance to glycopeptides.
抗生素作用靶点的改变是一种常见的耐药机制。无论抗生素的作用机制如何,每一类抗生素都能找到显示耐药性的临床菌株实例。靶点改变通常源于染色体上细菌基因的自发突变,并在抗生素存在的情况下发生选择。实例包括RNA聚合酶和DNA回旋酶的突变,分别导致对利福霉素类和喹诺酮类药物产生耐药性。在其他情况下,获得耐药性可能涉及通过某种形式的基因交换(接合、转导或转化)从其他生物体转移耐药基因。这些机制的实例包括金黄色葡萄球菌中获得编码耐甲氧西林的mecA基因,以及肠球菌中各种编码对糖肽类耐药的van基因。